Reported 196,867 shares, up 3,152 (1.6%) from the prior quarter.
Reported value -47.8%; share count 1.6% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 281000 |
| 2021-12-31 | 291000 |
| 2022-03-31 | 347000 |
| 2022-06-30 | 181000 |
| 2022-09-30 | 240000 |
| 2022-12-31 | 154797 |
| 2023-03-31 | 232399 |
| 2023-06-30 | 238166 |
| 2023-09-30 | 127579 |
| 2023-12-31 | 138242 |
| 2024-03-31 | 141258 |
| 2024-06-30 | 92367 |
| 2024-09-30 | 79064 |
| 2024-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2024 | Reduced | 0 | -157,938 (-100.0%) | 0 | $0 | 2025-02-07 | |
| Q3 2024 | Reduced | 157,938 | -306 (-0.2%) | < 0.01% | $79,064 | 2024-10-17 | |
| Q2 2024 | Added | 158,244 | +818 (0.5%) | 0.01% | $92,367 | 2024-08-08 | |
| Q1 2024 | Reduced | 157,426 | -25,313 (-13.9%) | 0.02% | $141,258 | 2024-05-07 | |
| Q4 2023 | Reduced | 182,739 | -3,671 (-2.0%) | 0.02% | $138,242 | 2024-02-12 | |
| Q3 2023 | Reduced | 186,410 | -12,062 (-6.1%) | 0.02% | $127,579 | 2023-10-26 | |
| Q2 2023 | Reduced | 198,472 | -160 (-0.1%) | 0.05% | $238,166 | 2023-07-31 | |
| Q1 2023 | Added | 198,632 | +2,686 (1.4%) | 0.05% | $232,399 | 2023-04-24 | |
| Q4 2022 | Reduced | 195,946 | -2,459 (-1.2%) | 0.04% | $154,797 | 2023-01-26 | |
| Q3 2022 | Added | 198,405 | +1,538 (0.8%) | 0.07% | $240,000 | 2022-11-07 | |
| Q2 2022 | Added | 196,867 | +3,152 (1.6%) | 0.05% | $181,000 | 2022-08-10 | |
| Q1 2022 | Added | 193,715 | +4,919 (2.6%) | 0.1% | $347,000 | 2022-04-21 | |
| Q4 2021 | Added | 188,796 | +50,583 (36.6%) | 0.08% | $291,000 | 2022-02-03 | |
| Q3 2021 | Added | 138,213 | +2,705 (2.0%) | 0.09% | $281,000 | 2021-11-09 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
86 managers reported CITIUS PHARMACEUTICALS INC for Q2 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | Reduced | 5,735,361 | -481,277 | < 0.01% | $5,276,000 | 19 qtrs |
| BlackRock Inc | Reduced | 2,346,024 | -5,736,155 | < 0.01% | $2,159,000 | 6 qtrs |
| MILLENNIUM MANAGEMENT LLC | New | 1,740,220 | +1,740,220 | < 0.01% | $1,601,000 | 1 qtr |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 1,310,059 | -962,086 | < 0.01% | $1,205,000 | 9 qtrs |
| Ergoteles LLC | New | 451,890 | +451,890 | 0.01% | $416,000 | 1 qtr |
| STATE STREET CORPORATION | Reduced | 442,597 | -1,623,970 | < 0.01% | $407,000 | 5 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Added | 380,470 | +341,170 | < 0.01% | $350,000 | 7 qtrs |
| NORTHERN TRUST CORPORATION | Reduced | 237,747 | -825,670 | < 0.01% | $219,000 | 10 qtrs |
| CITADEL ADVISORS LLC | Added | 235,870 | +123,849 | < 0.01% | $217,000 | 10 qtrs |
| The Goldman Sachs Group Inc | Added | 221,256 | +72,222 | < 0.01% | $203,000 | 5 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2022
- Filed
- August 10, 2022
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 196,867
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.